Tag: chemistry
-
Trial Advances of Dual-Action Cancer Immunotherapy
A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study.
-
Digital Chemistry Start-Up Gains $43M in Early Funds
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round.
-
Trial Cleared for Lab-Grown Replacement Knee Cartilage
A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage.
-
One-Time Crispr HIV Therapy Given Fast-Track Status
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration.
-
Darpa Seeking On-Demand, Distributed Production of Proteins
A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins.
-
Bio-Friendly Plant Nutrient Delivery Patent Awarded
A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent.
-
Synthetic DNA Company Gains $10M in Venture Round
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round.
-
Automated Life Science A.I. Generation System Unveiled
A bioengineering lab created a system to make it easier for life scientists to use machine learning for data analysis, without writing their own algorithms.
-
Patent Issued for Synthetic Peptide Chain Techniques
A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins.
-
Biotech Start-Up to Discover Cystic Fibrosis Therapy
A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder.